Voriconazole is a triazole antifungal drug that inhibits ergosterol synthesis and has broad activity 25 against yeast and moulds. While studying the interaction of voriconazole and Cryptococcus 26 neoformans, we noted that cells grown in the presence of sub-inhibitory concentrations of 27 voriconazole reduced melanin pigmentation. We investigated this effect systematically by 28 assessing melanin production in the presence of voriconazole, amphotericin B, caspofungin, 
INTRODUCTION 37
Voriconazole, a synthetic derivative of fluconazole, is a broad-spectrum triazole 38
antifungal that inhibits cytochrome P450 dependent 14α-lanosterol demethylation, which is a 39 critical step in fungal cell membrane ergosterol synthesis. We have previously shown that 40 experiments to establish proof of principle for the effect of this drug class on melanin production. 62
C. neoformans serotype D strain 24067 from the American Type Culture Collection (Rockville, 63 MD) was selected for these studies since it was used in our prior melanin and cellular 64 morphology studies (8, 10, 12) 
A C C E P T E D
oxidize ABTS (Fig. 4) . When 0.5 MIC of voriconazole was added to suspensions of cryptococci 220 or to cytoplasmic extracts of the fungus, voriconazole dramatically inhibited the activity of the 221 fungal laccases. In order to reproducibly examine these interactions, a commercial standardized 222 recombinant laccase from Rhus vernificera was used to demonstrate that voriconazole inhibited 223 the activity in a dose dependent fashion (Fig. 5A) . Similarly, reducing laccase in the presence of 224 a constant concentration of voriconazole resulted in a dose dependent reduction in activity (Fig. 225 antifungal drug or in the presence of sub-inhibitory concentrations of fluconazole (Fig. 6) . The experiment was done twice and similar results were obtained. 306 
